These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 11067800)

  • 1. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs.
    Lüscher TF; Barton M
    Circulation; 2000 Nov; 102(19):2434-40. PubMed ID: 11067800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease.
    Barton M; Kiowski W
    Curr Hypertens Rep; 2001 Aug; 3(4):322-30. PubMed ID: 11470015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies?
    Rossi GP; Pitter G
    Ann N Y Acad Sci; 2006 Jun; 1069():34-50. PubMed ID: 16855133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.
    Spieker LE; Noll G; Lüscher TF
    Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.
    Doggrell SA
    Expert Opin Investig Drugs; 2002 Nov; 11(11):1537-52. PubMed ID: 12437501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure.
    Zolk O; Quattek J; Sitzler G; Schrader T; Nickenig G; Schnabel P; Shimada K; Takahashi M; Böhm M
    Circulation; 1999 Apr; 99(16):2118-23. PubMed ID: 10217651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin antagonists for hypertension and renal disease.
    Barton M; Luscher TF
    Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):549-56. PubMed ID: 10541216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endothelins and their receptors in heart failure.
    Giannessi D; Del Ry S; Vitale RL
    Pharmacol Res; 2001 Feb; 43(2):111-26. PubMed ID: 11243712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis.
    Grantham JA; Schirger JA; Wennberg PW; Sandberg S; Heublein DM; Subkowski T; Burnett JC
    Circulation; 2000 Apr; 101(16):1976-81. PubMed ID: 10779465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
    Maguire JJ; Kuc RE; Davenport AP
    Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of endothelin-converting enzyme inhibitors for the treatment of cardiovascular diseases.
    Jeng AY
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1076-81. PubMed ID: 14582451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?
    Kirkby NS; Hadoke PW; Bagnall AJ; Webb DJ
    Br J Pharmacol; 2008 Mar; 153(6):1105-19. PubMed ID: 17965745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications.
    Jeng AY; Mulder P; Kwan AL; Battistini B
    Can J Physiol Pharmacol; 2002 May; 80(5):440-9. PubMed ID: 12056551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pharmacology of endothelin converting enzymes.
    Turner AJ; Murphy LJ
    Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the pharmacological effects of endothelin.
    Wilson C; Hargreaves RB
    Prog Med Chem; 1994; 31():371-410. PubMed ID: 8029479
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelin-1 inhibits endothelin-converting enzyme-1 expression in cultured rat pulmonary endothelial cells.
    Naomi S; Iwaoka T; Disashi T; Inoue J; Kanesaka Y; Tokunaga H; Tomita K
    Circulation; 1998 Jan; 97(3):234-6. PubMed ID: 9462522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents.
    Ergul A
    Pharmacotherapy; 2002 Jan; 22(1):54-65. PubMed ID: 11794430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paracrine endothelin system: pathophysiology and implications in clinical medicine.
    Hocher B; Thöne-Reineke C; Bauer C; Raschack M; Neumayer HH
    Eur J Clin Chem Clin Biochem; 1997 Mar; 35(3):175-89. PubMed ID: 9127739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal endothelin system in the Prague hypertensive rat, a new model of spontaneous hypertension.
    Vogel V; Bäcker A; Heller J; Kramer HJ
    Clin Sci (Lond); 1999 Jul; 97(1):91-8. PubMed ID: 10369799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin: new discoveries and rapid progress in the clinic.
    Webb DJ; Monge JC; Rabelink TJ; Yanagisawa M
    Trends Pharmacol Sci; 1998 Jan; 19(1):5-8. PubMed ID: 9509892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.